-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Ensysce Biosciences, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q3 2020 to Q3 2025.
- Ensysce Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 2,886,059, a 338% increase year-over-year.
- Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 697,686, a 362% increase from 2023.
- Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 150,937, a 16% decline from 2022.
- Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 179,925, a 99% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)